Karen Kennerley, who has been diagnosed with terminal colon cancer, has spoken about the symptom she experienced that wasn't ...

Transarterial chemoembolization (TACE) is a type of treatment for liver cancer. It works by delivering chemotherapy drugs directly to the tumor and blocking its blood supply. Liver cancer occurs ...

Thus although TAE is similar to TACE, it cannot be considered a definitive treatment for HCC but is a valuable option for patients with HCC without curative options. The high rate of local ...

"I worked in a small school for SEN pupils, I was working really hard at the time - I was exhausted. I went to my GP, who ran ...

The panelist discusses how for patients initially eligible for embolization, systemic therapy may be combined with ...

The panelist discusses, for intermediate-stage unresectable hepatocellular carcinoma (uHCC), key clinical pearls include ...

Teng observed that while TACE has been established as a standard treatment for intermediate HCC, long-term survival has been limited, resulting in an unmet need for improved survival benefits.

For patients with unresectable, non-metastatic hepatocellular carcinoma, Lenvima plus Keytruda in combination with TACE improved outcomes. Among patients with unresectable, non-metastatic ...

Progression-free survival was significantly greater in the durvalumab plus bevacizumab group compared to placebo. 2. Common treatment-related adverse events included hypertension and anemia. Evidence ...

Although the therapeutic benefit of TACE has been only demon­strated in patients with HCC without curative options, it is currently being used as a bridge therapy for patients awaiting LT ...